2 recruiting, 1 active not recruiting, 1 completed, 1 unknown. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 2, Active not recruiting 1, Completed 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Locally Advanced Gastric Carcinoma: new trials by email Literature Review of Locally Advanced Gastric Carcinoma trials Research Report on Locally Advanced Gastric Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer Olanzapine, Placebo Administration, Questionnaire Administration - Advanced Malignant Solid Neoplasm, Advanced Biliary Tract Carcinoma | Phase 2 | Recruiting | OHSU Knight Cancer Institute | 66 | 2024-07-17 | 2026-07-16 |
| Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer Tirolizumab+SOX/XELOX, SOX/XELOX - Locally Advanced Gastric Carcinoma, HER2 Negative | Phase 2 | Unknown | Lin Chen | 80 | 2023-10-01 | 2024-02-29 |
| Toripalimab Plus FLOT in Locally Advanced Gastric Cancer FLOT combined with toripalimab - Chemotherapy, Immune Checkpoint Inhibitor | Phase 2 | Recruiting | Henan Cancer Hospital | 60 | 2021-06-25 | 2024-06-06 |
| Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations Biopsy Procedure, Biospecimen Collection, Computed Tomography - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 29 | 2021-04-26 | 2026-11-05 |
| Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell Bevacizumab, docetaxel oxaliplatin 5-FU CF, Gastrectomy - Locally Advanced Gastric Carcinoma | Phase 1 / Phase 2 | Completed | Chinese PLA General Hospital | 86 | 2009-02-01 | 2014-04-25 |
Anorexia (1) · Breast Neoplasms (1) · Cachexia (1) · Colorectal Neoplasms (1) · Esophageal Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Prostatic Neoplasms (1) · Stomach Neoplasms (1) · Weight Loss (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Neoplasms by Site (2) · Pathological Conditions, Signs and Symptoms (2) · Adnexal Diseases (1) · Body Weight (1) · Body Weight Changes (1) · Breast Diseases (1) · Colonic Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Esophageal Diseases (1) · Female Urogenital Diseases (1)
Bevacizumab (1) · Biopsy (1) · Gastrectomy (1) · Magnetic Resonance Spectroscopy (1) · Olanzapine (1) · Specimen Handling (1) · talazoparib (1) · toripalimab (1)
Chinese PLA General Hospital (1) · Henan Cancer Hospital (1) · Lin Chen (1) · National Cancer Institute (NCI) (1) · OHSU Knight Cancer Institute (1)
China (3) · United States (2)
A P Chen (1) · Eric Roeland, M.D., FAAHPM, FASCO (1) · Nan Du, Phd (1) · Quanli Gao, M.D (1)
P30CA069533 (1)